000 | 00991 a2200289 4500 | ||
---|---|---|---|
005 | 20250517143005.0 | ||
264 | 0 | _c20180625 | |
008 | 201806s 0 0 eng d | ||
022 | _a1474-5488 | ||
024 | 7 |
_a10.1016/S1470-2045(17)30172-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPostow, Michael A | |
245 | 0 | 0 |
_aA step forward for patients with NRAS-mutant melanoma. _h[electronic resource] |
260 |
_bThe Lancet. Oncology _c04 2017 |
||
300 |
_a414-415 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Comment | ||
650 | 0 | 4 |
_aGTP Phosphohydrolases _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMelanoma |
650 | 0 | 4 |
_aMembrane Proteins _xgenetics |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aProto-Oncogene Proteins B-raf _xgenetics |
650 | 0 | 4 | _aSkin Neoplasms |
700 | 1 | _aChapman, Paul B | |
773 | 0 |
_tThe Lancet. Oncology _gvol. 18 _gno. 4 _gp. 414-415 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(17)30172-9 _zAvailable from publisher's website |
999 |
_c26959613 _d26959613 |